Skip to main content

LIVE

CBLL

CeriBell, Inc.

CBLL

NASDAQ·Healthcare·Medical - Devices·Mkt cap $900.4M

$23.73

+1.54%

P/E

-32.51

Mkt Cap

$900.4M

52-Wk Range

$10.85–$25.33

52-Week Range

$10.85 - $25.33

P/E

-32.51

Fwd P/E

-12.03

Beta

0.81

Div Yield

0.00%

Avg Vol

365.7K

Shares Out

37.6M

Mkt Cap

$900.4M

Price action

Price chart

Up 107.8% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

3 reasons

  • Proprietary AI algorithms for real-time neurological detection
  • Portable, user-friendly point-of-care platform vs. traditional EEG systems
  • FDA-cleared technology with clinical validation in acute care settings

Bear Case

1 risk

  • Average volatility.

Growth

Moderate growth ahead

Rising prevalence of seizure disorders and neurological emergencies

Value

Trading at 0.0x Medical Devices peers — a discount despite the growth profile.

Momentum

Hot

+28.6% over 3m

Quality

Excellent

High-growth business (32% revenue growth, 89% gross margin). Pre-profit but investing in growth.

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Nov 3, 2026

Q3 26 RECAP

AUG 10, 2026

Reported EPS of -$0.51 vs -$0.47 consensus (-8.2% surprise). Revenue of $28.1M vs $27.3M expected (+3.0%).

EPS miss
Rev beat +3.0%

EPS surprise · last 4Q

0 of 1 beats

Estimate

Actual

Q3 26

-8.2%

Revenue trend · last 8Q

+41%

+38%

+43%

+31%

+34%

+29%

+33%

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

Q2 26

$17.2M

$18.5M

$20.5M

$21.2M

$22.6M

$24.8M

$26.5M

$28.1M

Margins · last 8Q

Gross

92.3%

Operating

-71.1%

Profit

70.3%

Wall Street consensus

1 analyst · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

1

100%

Hold

0%

Sell

0%

Median Price Target

Latest: Canaccord · $25.00 · May 12, 2026

vs Industry

How CBLL stacks vs Medical - Devices

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.